End-stage renal disease in the Northern Territory: Current and future treatment costs

Medical Journal of Australia

Volumn 176, Issue 10, 2002, Pages 461-465

  You, Jiqiong ^a   Hoy, Wendy ^a   Zhao, Yuejen ^a   Beaver, Carol ^a   Eagar, Kathy ^a  

^a Health Gains Planning   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABORIGINE; ADULT; ARTICLE; AUSTRALIA; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FUTUROLOGY; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MODEL; PREDICTION AND FORECASTING; PREVALENCE;

EID: 0037141068     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04516.x     Document Type: Article

References (27)

1. Cost estimate for hospital inpatient care in Australia: Evaluation of alternative sources
2. Time series analysis of surveillance data of infectious diseases in Japan
3. Modeling and forecasting monthly patient volume at a primary health care clinic using univariate time-series analysis
4. Influenza A and B epidemic criteria based on time-series analysis of health services surveillance data
5. Time series designs of potential interest to epidemiologists
6. US health services employment: A time series analysis
7. Provision of health care services in Austria. A time series approach
8. Time series analysis of mortality and unemployment
9. The cost of caring for end-stage kidney disease patients: An analysis based on hospital financial transaction records
10. Current strategies for retarding progression of renal disease
11. Nephron mass as a risk factor for progression of renal disease
12. Are glomerular hypertension and "hypertrophy" independent risk factors for progression of renal disease?
13. The multidimensional nature of renal disease: Rates and associations of albuminuria in an Australian Aboriginal community
14. Reducing premature death and renal failure in Australian aboriginals. A community-based cardiovascular and renal protective program
15. Early referral to the nephrologist and timely initiation of renal replacement therapy: A paradigm shift in the management of patients with chronic renal failure
16. Renal disease in the managed care setting: Selection and monitoring or outcome criteria